PDS Biotechnology Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 15
Employees
  • Stock Symbol
  • PDSB
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $15.99
  • (As of Wednesday Closing)

PDS Biotechnology General Information

Description

PDS Biotechnology Corp operates as a clinical-stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 303A College Road East
  • Princeton, NJ 08540
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PDS Biotechnology Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.99 $14.96 $1.87 - $16.67 $425M 28.4M 540K -$0.53

PDS Biotechnology Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 331,544 14,809 (2,093) (26,759)
Revenue 0 0 0 0
EBITDA (16,079) (14,887) (7,602) (42,922)
Net Income (11,570) (14,847) (6,999) (40,868)
Total Assets 77,391 30,890 14,491 36,221
Total Debt 553 610 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PDS Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PDS Biotechnology‘s full profile, request access.

Request a free trial

PDS Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
PDS Biotechnology Corp operates as a clinical-stage biotechnology company, principally involved in drug discovery in the
Biotechnology
Princeton, NJ
15 As of 2020
000.00
00000000 000.00

00000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cill
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
Rockville, MD
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PDS Biotechnology Competitors (71)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000000000 Formerly VC-backed Rockville, MD 00 00000 00000000 00000
000000 000 Formerly VC-backed Menlo Park, CA 00 00000 00000000 00000
0000000 0000000000 Venture Capital-Backed South San Francisco, CA 00 00000 00000000 00000
0000000 000000 Formerly VC-backed New York, NY 000 00000 00000000 00000
You’re viewing 5 of 71 competitors. Get the full list »

PDS Biotechnology Executive Team (8)

Name Title Board Seat Contact Info
Frank Bedu-Addo Ph.D Chief Executive Officer & Board Member
Seth Voorhees Ph.D Chief Financial Officer
Gregory Conn Ph.D Chief Scientific Officer
Richard Sykes Executive Chairman
Robert Shepard MD Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

PDS Biotechnology Board Members (15)

Name Representing Role Since
DeLyle Bloomquist Self Board Member 000 0000
Frank Bedu-Addo Ph.D PDS Biotechnology Chief Executive Officer & Board Member 000 0000
Gregory Freitag JD Self Board Member 000 0000
Ian Postlethwaite NetScientific Board Member 000 0000
Ilian Iliev Ph.D Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

PDS Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PDS Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PDS Biotechnology‘s full profile, request access.

Request a free trial

PDS Biotechnology Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000000000 15-Mar-2019 000000000000000000 000.00 Other Healthcare Technology Systems 00000 0000-0000 00.0
To view PDS Biotechnology’s complete acquisitions history, request access »